Shares of H&H International Holdings (SEHK: 01112) experienced a significant surge of more than 10% in today's trading session.

At the time of writing, the stock was up 10.25%, trading at HK$12.48 with a turnover of HK$14.14 million.

Strong Revenue Growth and Profit Forecast

The company announced that for the six-month period ending June 30, 2026, its total revenue achieved a double-digit year-on-year increase on a comparable basis.

This growth was driven by expansion across all business segments, including Adult Nutrition and Care Products, Baby Nutrition and Care Products, and Pet Nutrition and Care Products.

Infant Formula Segment Performance

Within the Baby Nutrition and Care segment, revenue from infant formula products grew by more than 50%.

The company's Biostime brand continued to gain market share in the super-premium infant formula segment in mainland China, increasing its share from 14.6% last year to 20.0%.

Significant Profit Increase Expected

Benefiting from a substantial rise in adjusted comparable EBITDA, an optimized debt structure, and a reduction in overall financing costs, the group anticipates its adjusted comparable net profit for the six months ending June 30, 2026, will increase by over 100% compared to the same period last year.

Regarding the group's reported net profit under International Financial Reporting Standards, due to a low base in the prior-year period, it is forecast to achieve rapid growth exceeding 700%.